ALS patients have elevated PDGFC expression, and activation of the PDGF‐CC signaling pathway via PDGFR‐α leads to an earlier onset of neurodegeneration in ALS mouse models 116, suggesting that modulation of this signaling pathway may be a potential therapeutic strategy for ALS. The gene discussed is PDGFC; the disease is amyotrophic lateral sclerosis.